The Fly
Mon, March 16, 2026 astatine 8:37 AM CDT 4 min read
The astir talked astir and marketplace moving probe calls astir Wall Street are present successful 1 place. Here are today's probe calls that investors request to know, arsenic compiled by The Fly.
Top 5 Upgrades:
-
Arete upgraded Trade Desk (TTD) to Neutral from Sell with a $25 terms target. The steadfast sees unit connected absorption to "restore capitalist confidence" with shares down 49% successful the past 12 months.
-
Berenberg upgraded Ecolab (ECL) to Buy from Hold with a terms people of $326, up from $300. The steadfast expects the terms increases to beryllium implemented swiftly and go a "sticky constituent of Ecolab's structural pricing, alternatively than being rolled back."
-
Keefe Bruyette upgraded PennyMac Financial (PFSI) to Outperform from Market Perform with an unchanged terms people of $115. The steadfast cites valuation for the upgrade with 38% upside to the terms target.
-
Keefe Bruyette upgraded Rocket Companies (RKT) to Outperform from Market Perform with a terms people of $22, up from $20. The steadfast cites valuation for the upgrade with shares down 25% year-to-date.
Top 5 Downgrades:
-
Seaport Research downgraded Qualcomm (QCOM) to Sell from Neutral with a $100 terms target. The representation crunch is apt going to wounded Qualcomm's customers the hardest, argues the firm, which views the institution arsenic acceptable to suffer stock adjacent portion its addressable marketplace shrinks this year.
-
Argus downgraded Adobe (ADBE) to Hold from Buy. Adobe reported a 12% maturation successful operating income successful Q1, and the institution continues to innovate leveraging generative AI innovations rapidly crossed its merchandise set, though its results were overshadowed by the announcement that 18-year CEO Narayan has decided to measurement down, the steadfast tells investors successful a probe note.
-
Jefferies downgraded Incyte (INCY) to Hold from Buy with a terms people of $94, down from $120, aft transportation successful expert coverage. The steadfast cites patent cliff concerns for the downgrade.
-
Jefferies downgraded Alnylam (ALNY) to Hold from Buy with a terms people of $330, down from $522, aft transportation successful expert coverage. The steadfast is "impressed" with the company's RNAi level but says the shares are "priced to perfection."
-
Jefferies downgraded Immunocore (IMCR) to Hold from Buy with a terms people of $33, down from $48, aft transportation successful expert coverage. While Immunocore has a existent merchandise successful Kimmtrak, uveal melanoma is simply a mean full addressable marketplace and its income are approaching peak, the steadfast tells investors successful a probe note.

1 week ago
11




English (CA) ·
English (US) ·
Spanish (MX) ·